We are live on ! Find out more
B

Bellecapital Portfolio holdings

AUM $554M
1-Year Est. Return 29.39%
This Fund
S&P 500
This Quarter Est. Return
+5.08%
1 Year Est. Return
+29.39%
3 Year Est. Return
+99.7%
5 Year Est. Return
+120.39%
10 Year Est. Return
+406.87%
AUM
$472M
AUM Growth
+$17.9M
Cap. Flow
-$5.7M
Cap. Flow %
-1.21%
Top 10 Hldgs %
41.49%
Holding
167
New
7
Increased
37
Reduced
41
Closed
18

Top Buys

Rank Stock Value
1
XMTR icon
Xometry
XMTR
+$8.54M
2
PFE icon
Pfizer
PFE
+$3.01M
3
CSCO icon
Cisco
CSCO
+$2.08M
4
ZTS icon
Zoetis
ZTS
+$2.07M
5
AMD icon
Advanced Micro Devices
AMD
+$1.87M

Sector Composition

Rank Sector Weight
1 Technology 31.06%
2 Healthcare 13.47%
3 Consumer Staples 12.2%
4 Consumer Discretionary 12.04%
5 Communication Services 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRBR icon
151
BellRing Brands
BRBR
$1.41B
-4,355
Closed -$257K
CI icon
152
Cigna
CI
$74.7B
-585
Closed -$212K
CIFR icon
153
Cipher Digital
CIFR
$7.9B
-24,650
Closed -$127K
MDT icon
154
Medtronic
MDT
$106B
-6,058
Closed -$528K
MEDP icon
155
Medpace
MEDP
$15.3B
-642
Closed -$259K
MTZ icon
156
MasTec
MTZ
$26.8B
-3,495
Closed -$326K
NVT icon
157
nVent Electric
NVT
$25.6B
-3,287
Closed -$248K
RS icon
158
Reliance Steel & Aluminium
RS
$20.1B
-612
Closed -$205K
RSP icon
159
Invesco S&P 500 Equal Weight ETF
RSP
$96B
-36,000
Closed -$6.1M
VEA icon
160
Vanguard FTSE Developed Markets ETF
VEA
$226B
-10,942
Closed -$549K
VOO icon
161
Vanguard S&P 500 ETF
VOO
$980B
-697
Closed -$335K
VWO icon
162
Vanguard FTSE Emerging Markets ETF
VWO
$119B
-6,781
Closed -$283K
VYM icon
163
Vanguard High Dividend Yield ETF
VYM
$80.2B
-2,375
Closed -$287K

Similar funds

Bellecapital's Q2 2024 Portfolio in Review

As of Q2 2024, Bellecapital held 167 positions worth $472M, up 3.9% from $454M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Bellecapital's Q2 2024 filing shows 7 new, 37 increased, 41 reduced and 18 closed positions. Its largest new stake was Xometry: 543,347 shares worth $6.28M. The largest sale was Coca-Cola, an estimated $7.79M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Bellecapital's largest Q2 2024 buy was Xometry: 543,347 shares worth $6.28M.
  • Bellecapital added most to Pfizer in Q2 2024, an estimated $3.01M increase.
  • Bellecapital's biggest Q2 2024 reduction was Coca-Cola, cutting an estimated $7.79M.
  • Bellecapital fully exited Invesco S&P 500 Equal Weight ETF in Q2 2024, selling an estimated $6.1M.
  • Bellecapital's ten largest holdings make up 41% of its $472M portfolio in Q2 2024.
  • Bellecapital opened 7 new positions and closed 18 in Q2 2024.
  • Bellecapital's portfolio value rose 3.9% quarter-over-quarter to $472M.

Based on Bellecapital's 13F filing for Q2 2024, filed 19 Jul 2024.